Cargando…
Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells
Inhibition of the proteasome is a widely used strategy for treating multiple myeloma that takes advantage of the heavy secretory load that multiple myeloma cells (MMCs) have to deal with. Resistance of MMCs to proteasome inhibition has been linked to incomplete disruption of proteasomal endoplasmic-...
Autores principales: | Auner, Holger W., Moody, Anne Marie, Ward, Theresa H., Kraus, Marianne, Milan, Enrico, May, Philippa, Chaidos, Aristeidis, Driessen, Christoph, Cenci, Simone, Dazzi, Francesco, Rahemtulla, Amin, Apperley, Jane F., Karadimitris, Anastasios, Dillon, Niall |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775786/ https://www.ncbi.nlm.nih.gov/pubmed/24069311 http://dx.doi.org/10.1371/journal.pone.0074415 |
Ejemplares similares
-
Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure()
por: Pitcher, David S., et al.
Publicado: (2015) -
Brd2/4 and Myc regulate alternative cell lineage programmes during early osteoclast differentiation in vitro
por: Caputo, Valentina S., et al.
Publicado: (2020) -
On the Secretory Apparatus of the Liver
por: Jones, C. Handfield
Publicado: (1850) -
Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma
por: Alvarez-Benayas, Jaime, et al.
Publicado: (2021) -
The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma
por: Ponnusamy, Kanagaraju, et al.
Publicado: (2021)